Results 171 to 180 of about 846,391 (207)
Some of the next articles are maybe not open access.
Familial Mediterranean Fever (FMF) and Pregnancy: Literature Review
Nauchno-prakticheskii zhurnal «Medicinskaia genetika», 2020В обзоре обобщается текущая информация о влиянии семейной средиземноморской лихорадки (ССЛ) и ее лечения на исходы беременности, анализируется вопрос гипотетической тератогенности колхицина. В случае резистентности/непереносимости колхицина обсуждается возможность использования других лекарственных средств во время беременности, в том числе, генно ...
openaire +1 more source
Normal QT dispersion in colchicine-resistant familial Mediterranean fever (FMF)
Clinical Rheumatology, 2012The association between familial Mediterranean fever (FMF) and subclinical cardiac disease remains controversial. The aim of the current study was to evaluate whether FMF patients, who do not respond to colchicine treatment, and thereby endure persistent inflammation, have increased QT dispersion (QTd) values.
Udi, Nussinovitch +6 more
openaire +2 more sources
A novel cluster of patients with Familial Mediterranean Fever (FMF) in southern Italy
European Journal of Clinical Investigation, 2017AbstractBackgroundFamilial Mediterranean Fever (FMF) is an autosomal recessive autoinflammatory disorder characterised by recurrent attacks of fever and serositis (peritonitis, pleuritic or synovitis) affecting mainly populations of Mediterranean origin.AimTo describe a relatively new cluster of FMF subjects from Apulia and Basilicata regions (southern
Leonilde Bonfrate +4 more
openaire +3 more sources
The Impact of Colchicine on the Amyloidosis of Familial Mediterranean Fever (FMF)
1986Since Goldfinger’s observation in 1972 that daily administration of colchicine may prevent the attacks of familial Mediterranean fever [1], the drug has become the mainstay of therapy and is recommended to all of our many afflicted. On a dose of 102 mg/day, 95% of patients experience complete remission or marked amelioration of their attacks.
D. Zemer +4 more
openaire +1 more source
The immune regulation in familial Mediterranean fever (FMF).
Journal of clinical & laboratory immunology, 1989In order to investigate a possible immune regulation imbalance in familial Mediterranean fever (FMF), the T-cell subsets and interleukin (IL)-1 and -2 production were examined in 39 patients (32 consecutive; 7 previous) and 14 controls. Results in the FMF group indicated no change in total T-cells and B-cells.
A, Melamed +3 more
openaire +1 more source
[Familial Mediterranean fever (FMF) (author's transl)].
Anales espanoles de pediatria, 1981Authors present an Andalusian family, affected by FMF with a dominant autosomal inheritance. The number of members affected by phenotype II (40%) and the cases of bad prognosis (1/3 died before 34 years of age) was higher than those found by other authors.
M A, Ribó Golovart +4 more
openaire +1 more source
The arthritis of familial mediterranean fever (FMF)
Arthritis & Rheumatism, 1966H, Heller +7 more
openaire +2 more sources
PATH TO DIAGNOSIS IN FAMILIAL MEDITERRANEAN FEVER (FMF)
[No abstract available]Karup, Sejla +6 more
openaire +2 more sources
[Familial Mediterranean Fever (FMF): from diagnosis to treatment].
Sante (Montrouge, France), 2005Familial Mediterranean Fever (FMF), also known as paroxysmal polyserositis, is an autosomal recessive disease affecting mainly Mediterranean populations (Jews, Armenians, Arabs, Turks). It is characterised by recurrent crises of fever and serosal inflammation, leading to abdominal, thoracic or articular pain.
Myrna, Medlej-Hashim +3 more
openaire +1 more source